INTERCEPTING BRAIN METASTASES THROUGH METABOLIC VULNERABILITIES

BTFC travel award recipient Patients with brain metastases (BM) face a 90% mortality rate within one year of diagnosis because the current standard of care is mainly palliative. Our patient-derived xenograft models have successfully recapitulated all the stages of the metastatic cascade and captured...

Descripción completa

Detalles Bibliográficos
Autores principales: Kieliszek, A M, Mobilio, D, Bassey-Archibong, B I, Johnson, J W, Piotrowski, M L, Aghaei, N, Gwynne, W D, Escudero, L, Chafe, S, Zhang, K Zhai1 C, Quaile, A, McKenna, D, Subapanditha, M, de Araujo, E D, Sedighi, A, Gunning, P T, Tokar, T, Venugopal, C, Montenegro-Burke, J R, Magolan, J, Singh, S K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Young Investigator Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337573/
http://dx.doi.org/10.1093/noajnl/vdad071.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337573/
http://dx.doi.org/10.1093/noajnl/vdad071.007

Ejemplares similares